MicrobiologybioRxiv
Potent mouse monoclonal antibodies that block SARS-CoV-2 infection
Y. Guo, A. Kawaguchi, M. Takeshita…·K. Murano
This study develops mouse monoclonal antibodies against SARS-CoV-2 spike protein that show neutralizing activity and are suitable for immunoassays and large-scale production.
DOI 10.1016/j.jbc.2021.100346